4Beck LH, Bonegio RC, Lambeau G, et al. M-type phospho- lipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009, 36l(1) : 11-2l. 被引量：1
5Chen M, Li H, Li XY, et al. Tacrolimus combined with corti costeroids in treatment of nephrotic idiopathic membranous ne phropathy., amuhicenter randomized controlled trial[J], Am J Sci, 2010, 339(3): 233-238. 被引量：1
9He L, Peng Y, Liu H, et al. Treatment of idiopathic membra- nous nephropathy with combination of low-dose tacrolimus and corticosteroids[J]. J Nephrol, 2013, 26(3): 564-571. 被引量：1
5Stargl T E,Fung J,Jordan M,et al.Kidney transplantation under FK506[J].J Am,Med Assoc,1990,264(1):63-67. 被引量：1
6Shaw K T,Ho A M,Raghavan A,et al.Immunosuppressive drugs Prevent a rapid dephosphorylatian of transcription factor NFAT1 in stimulated immune cells[J].Proc Nail.Acad Sci USA,1995,92(24):11205-11209. 被引量：1
7Denys A,Allain F,Masy E,et al.Enhancing the effect of secret-ed cyclophilin B on immunosuppressive activity of eyelosporine[J].Transplantation,1998,65 (8):1076-1084. 被引量：1
8Undre N A,Stevenson P,Schafer A.Pharmacokineties of tacrolimus:clinically relevant aspects[J].Transplant Proc,1999,31 (7A):21 s-24s. 被引量：1
9Praga M,Barrio V,Juarez G F,et al.Tacrolimus monotherapy in membranous nephropathy:a randomized controlled tria I[J].Kidney Int,2007,71 (9):924-930. 被引量：1
10Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephritic syndrome in Japan [J]. Kidney int,2004,65(4) :1400-1407. 被引量：1
